Skip to main content
Premium Trial:

Request an Annual Quote

Court OKs Luminex's Stock-Swap Acquisition of Tm BioScience

NEW YORK (GenomeWeb News) — An Ontario Superior Court of Justice has cleared the way for Luminex to acquire Tm Bioscience, Tm said yesterday.
 
Tm last week said that the deal could close within a day of the court’s favorable decision.
 
As GenomeWeb News reported in December, the deal would exchange one Tm share for every .06 share of Luminex. Luminex said at the time that would be roughly a 41.5 percent premium for Tm’s shareholders.
 
One month earlier Tm initially said it was seeking a “strategic transaction” such as a merger or acquisition that would allow the company to begin selling worldwide its ID-Tag respiratory viral panel, which had just received European CE Mark clearance.
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.